Company Filing History:
1 out of 1,379 
1 out of 3 Years Active: 2025
Title: The Innovative Journey of Orhan Causevic
Introduction
Orhan Causevic, based in Martinsried, Germany, is a remarkable inventor who has made significant contributions to the field of enzyme therapy. With a patent to his name, he focuses on addressing serious health conditions, exemplifying the spirit of innovation in modern medicine.
Latest Patents
Orhan Causevic holds a patent for a groundbreaking treatment involving a PEGylated cystathionine beta synthase (CBS) protein. His patent, titled "Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria," provides formulations for a drug product designed to aid individuals suffering from homocystinuria. The patent includes specific dosages and dosing regimens aimed at reducing homocysteine levels and increasing cysteine and cystathionine levels in patients.
Career Highlights
Throughout his career, Orhan Causevic has worked with prestigious institutions that have bolstered his innovative pursuits. Notably, he has contributed his expertise at the University of Colorado, where academic research intersects with practical applications. Additionally, he has been associated with Travere Therapeutics Switzerland GmbH, furthering the development of therapeutic solutions in the pharmaceutical industry.
Collaborations
Orhan has collaborated with esteemed professionals in the field, including Erez Bublil and Frank Glavin. These partnerships have helped elevate his work and extended the reach of his inventions, fostering an environment of shared knowledge and innovation.
Conclusion
Orhan Causevic stands out as a key figure in the realm of enzyme therapy, with his patent addressing significant health challenges. His career, highlighted by associations with reputable institutions and collaborations with industry professionals, showcases his commitment to advancing medical science through innovative solutions. As he continues to explore new horizons in therapeutic development, the impact of his work is poised to resonate within the medical community and beyond.